Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-853 with Liposomal Doxorubicin in Solid Tumors
NCT00004030Phase 2Completed
- Sponsor
- Georgetown University
- Start
- Mar 1996
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timcodar in solid tumor, sponsored by Georgetown University. Started Mar 1996; status: completed.
02
Drugs
timcodar
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00004030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004030.